Secondary analysis reveals a combined redox and lipid expression state tied to elevated aflatoxin biosynthesis in Aspergillus flavus, highlighting metabolic drivers of crop contamination.
Background/Objectives: Aflatoxin B1 (AFB1) contamination of maize and peanut is influenced by fungal responses to environmental and food-matrix cues, but the transcriptional coordination of redox adaptation, lipid metabolism, and aflatoxin biosynthesis remains unresolved. This study examined whether an expression-defined redox–lipid state is associated with high relative aflatoxin biosynthetic activity in Aspergillus flavus. Methods: A cross-dataset secondary analysis integrated 18 analytical datasets (247 samples) derived from eight public source records spanning defined-medium, maize, and peanut systems. Harmonized expression profiles were used to derive an aflatoxin biosynthetic activity score (ABAS), oxidative-stress adaptation score (OSAS), and lipid metabolic reprogramming score (LMRS). ABAS is an expression-derived relative score, not a direct measure of biosynthetic flux or accumulated toxin. Dataset-aware mixed-effects models evaluated the OSAS–ABAS association and the linear OSAS × LMRS interaction. Results: ABAS correlated with matched AFB1 measurements in 54 samples (Pearson r=0.734, p=2.70×10−10). The quadratic OSAS term was negative (β=−0.434, 95% CI −0.502 to −0.366; p<0.001), with maximum predicted ABAS near 0.81 SD on the pooled within-dataset-standardized OSAS scale. Separately, the linear OSAS × LMRS interaction was positive (β=0.284, 95% CI 0.198–0.370; p<0.001), and the high-OSAS/high-LMRS quadrant had the greatest adjusted mean ABAS (0.789, 95% CI 0.661–0.917). Candidate prioritization recovered established regulators and nominated redox- and lipid-associated nodes. Conclusions: The findings identify an associative transcriptional signature across heterogeneous food-relevant conditions and provide focused hypotheses for prospective validation using direct toxin, redox, lipid, flux, and functional measurements.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: